Frequently asked questions
Find the answers to some frequently asked questions (FAQs) about PrEP, including DESCOVY FOR PrEP®.
DESCOVY FOR PrEP is indicated for at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation. It is a fixed dose of antiretroviral drugs, emtricitabine (FTC) and tenofovir alafenamide (TAF).1
Not all PrEP medication components are the same. Learn more about TDF and TAF pharmacology.